project id: TCGA-PAAD; case submitter id: TCGA-3A-A9IX; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.4; age at index: 40; days to birth: -14729; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1972; age at diagnosis: 14729; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1037.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 0.12602739726027398; pack years smoked: 2.3; years smoked: 22.0; is ffpe: false; composition: Not Reported; days to collection: 715; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-3A-A9IX-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 35.0; percent stromal cells: 0.0; percent tumor cells: 65.0; percent tumor nuclei: 25.0;